VM Pharma (TrkA Program) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

VM Pharma (TrkA Program) General Information

Description

VM-902A pharmaceutical product. The asset is used to develop VM-902A which is orally bioavailable, peripherally acting and allosteric selective tropomyosin receptor kinase for recovering of many diseases in USA.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • 45535 Northport Loop East
  • Fremont, CA 94538
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VM Pharma (TrkA Program) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore VM Pharma (TrkA Program)‘s full profile, request access.

Request a free trial

VM Pharma (TrkA Program) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore VM Pharma (TrkA Program)‘s full profile, request access.

Request a free trial

VM Pharma (TrkA Program) FAQs

  • Where is VM Pharma (TrkA Program) headquartered?

    VM Pharma (TrkA Program) is headquartered in Fremont, CA.

  • What industry is VM Pharma (TrkA Program) in?

    VM Pharma (TrkA Program)’s primary industry is Buildings and Property.

  • Is VM Pharma (TrkA Program) a private or public company?

    VM Pharma (TrkA Program) is a Private company.

  • What is the current valuation of VM Pharma (TrkA Program)?

    The current valuation of VM Pharma (TrkA Program) is 00000.

  • What is VM Pharma (TrkA Program)’s current revenue?

    The current revenue for VM Pharma (TrkA Program) is 000000.

  • Who are VM Pharma (TrkA Program)’s investors?

    VM Pharma has invested in VM Pharma (TrkA Program).

  • When was VM Pharma (TrkA Program) acquired?

    VM Pharma (TrkA Program) was acquired on 08-Sep-2015.

  • Who acquired VM Pharma (TrkA Program)?

    VM Pharma (TrkA Program) was acquired by Purdue Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »